An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients
- First Posted Date
- 2011-01-10
- Last Posted Date
- 2013-09-04
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 648
- Registration Number
- NCT01273454
Observational Study Investigating the Effectiveness of Fentanyl Matrix in Relieving Pain and Improving Function in Patients With Osteoarthritis of the Knee or Hip
- First Posted Date
- 2010-05-10
- Last Posted Date
- 2014-04-28
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 742
- Registration Number
- NCT01119885
An Efficacy and Safety Study of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen in Participants With Chronic Low-Back Pain
Phase 3
Completed
- Conditions
- Low Back Pain
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2013-07-24
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 248
- Registration Number
- NCT01112267
A Study of the Tolerability of Titrated Dose Tramadol/Acetaminophen Combination Tablet in Korean Patients With Osteoarthritis
Phase 4
Completed
- Conditions
- Osteoarthritis
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2010-02-05
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 250
- Registration Number
- NCT01063842
An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 103
- Registration Number
- NCT01060124
Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
Completed
- Conditions
- Hematological MalignanciesNeutropeniaFever
- Interventions
- Drug: Pts. w/ neutropenic fever associated w/ hematologic malignancy
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2014-05-15
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 438
- Registration Number
- NCT01060462
An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)
Phase 4
Completed
- Conditions
- Attention Deficit Disorder With Hyperactivity
- Interventions
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 115
- Registration Number
- NCT01060150
An Efficacy and Tolerability Study of Topiramate in Participants With Migraine
Phase 4
Completed
- Conditions
- Migraine
- Interventions
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2013-08-22
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 250
- Registration Number
- NCT01060111
Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2013-07-17
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 60
- Registration Number
- NCT01060202
Fentanyl Matrix in Lung Cancer Pain
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2010-02-05
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 268
- Registration Number
- NCT01060137
© Copyright 2025. All Rights Reserved by MedPath